Table 4 Base case economic results of RSBCS programmes.
From: The cost-effectiveness of risk-stratified breast cancer screening in the UK
Regimen | Undiscounted values per women | Discounted values per women | No. of screens per women | Total Diagnosis per 20,000 women | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Total cost | Total QALYs | Life years | Disc. costs | Disc. QALYs | NHB | DCIS | Inv. | Stage 3–4 | ||
No screening | £2411 | 27.931 | 35.809 | £1188 | 16.613 | 16.554 | 0.00 | 124 | 2613 | 580 |
PROCAS (PROCAS with a starting age of 50) | £3323 (£2915) | 28.180 (28.126) | 36.065 (36.020) | £1971(£1743) | 16.710(16.693) | 16.611 (16.605) | 6.30(5.24) | 376 (324) | 2827 (2412) | 491 (403) |
ASSURE 1 | £2805 | 28.089 | 36.002 | £1641 | 16.673 | 16.592 | 5.50 | 280 | 2457 | 414 |
ASSURE 2 | £2821 | 28.077 | 35.995 | £1649 | 16.667 | 16.585 | 5.94 | 294 | 2442 | 425 |
ASSURE 3 | £2953 | 28.040 | 35.981 | £1743 | 16.648 | 16.560 | 4.54 | 244 | 2492 | 433 |
ASSURE 4 | £3059 | 28.073 | 36.005 | £1825 | 16.663 | 16.572 | 5.23 | 296 | 2441 | 422 |
BRAID 2 | £3093 | 28.099 | 36.019 | £1876 | 16.676 | 16.582 | 8.49 | 315 | 2422 | 407 |
BRAID 3 | £3000 | 28.092 | 36.022 | £1804 | 16.671 | 16.581 | 8.49 | 321 | 2415 | 415 |
BRAID 4 | £3229 | 28.100 | 36.024 | £1972 | 16.676 | 16.577 | 8.49 | 317 | 2420 | 406 |
Current screening | £2703 | 28.023 | 35.963 | £1537 | 16.641 | 16.564 | 4.68 | 252 | 2485 | 469 |
